LPLDL impact on CVD Biomarkers

Press/Media: Press / Media

Period	20 Oct 2022

Media contributions

Title	LPLDL® from ProBiotix Health showcases statistically significant reductions in multiple coronary heart disease biomarkers in hypercholesterolemic adults
Country/Territory	United Kingdom
Date	20/10/22
URL	https://www.marketscreener.com/quote/stock/OPTIBIOTIX-HEALTH-PLC-17109489/news/OptiBiotix-Health-LPLDL-from-ProBiotix-Health-showcases-statistically-significant-reductions-in-m-37588035/
Persons	Adele Costabile